ACORI Call to Action Summit: Activating Equity in Community Oncology Research

You must have an ACCC account in order to register for this course/webinar/webinar series ACORI Call to Action Summit: Activating Equity in Community Oncology Research.

If You DO NOT Have An ACCC Account:

  • To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page.
    • ACCC members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page, where you can view and update your information.
    • OSS at ACCC Members: Please use your state society login credentials.
    • Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page, where you can view and update your information. Click “Change” to add your Areas of Concentration, then save your information.
  • Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link.
  • The green box in the upper right corner of this page will indicate “You are registered!” for this course. Congratulations!

If You Have An ACCC Account:

  • Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button.
  • You will be automatically redirected back to this course/webinar page, and the green box in the upper right corner will say that “You are registered!” for this course. Congratulations!

PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!

For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer Users may experience difficulties accessing the webinar.

Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this course/webinar . For assistance with registration or if you do not receive an email, please contact registration@accc-cancer.org.

image

The Association of Community Cancer Centers (ACCC) has established the ACCC Community Oncology Research Institute (ACORI) to build on its existing mission to close the gap in cancer research through optimal oncology partnerships. As part of this mission, ACCC hosted the ACORI Call to Action Summit, a two-day virtual event that explored practical solutions to strengthen and diversify oncology clinical trials in communities across the country.

The Summit's interactive discussions focused around:

  • The importance of expanding access to clinical trials for patients of all background—to ensure the highest quality care
  • Strategies for engaging patients and their caregivers in shared decision-making around trial enrollment
  • Case studies to demonstrate solutions for optimizing accrual and overcoming barriers to trial participation
  • Tools and resources to support care teams, including budget forms, IRB templates, etc.
  • How to incorporate the patient perspective into trial design: insights for trial sponsors   

This Summit is open to the public. You do not need to be an ACCC member to view this webinar, but you will need to create an account in order to register. Please click the "Registration Instructions" tab for more details.

This Summit is part of the ACCC Community Oncology Research Institute and is supported by AbbVie, Amgen, AstraZeneca, Eisai, Genentech, Merck and Sanofi.

Day 1: Panel Discussions

Advancing Health Equity through Community Cancer Research
Sybil Green, JD, RPh, MHA, Diversity and Inclusion Officer, ASCO (Moderator)
Karen Winkfield, MD, PhD, Executive Director, Meharry-Vanderbilt Alliance
Ysabel Duron, President/Executive Director, The Latino Cancer Institute
Linda Burhansstipanov, MSPH, DrPH, Founder, Native American Cancer Research Corporation; President, Native American Cancer Initiatives, Incorporated

Panel Conversation: Centering the Patient Perspective in Community Cancer Research
Jeanne Regnante, Chief Health Equity and Diversity Officer, LUNGevity Foundation (Moderator)
Shonta Chambers, MSW, Executive Vice President, Patient Advocate Foundation
Venus Ginés, MA, P/CHWI, CEO and Founder, Día de la Mujer Latina
Rodney Haring, PhD, MSW, Director, Center for Indigenous Cancer Research, Roswell Park Comprehensive Cancer Center

Fostering Readiness for Community Cancer Research
Nadine Barrett, PhD, MA, MS, Director, Office of Health Equity and Disparities, Duke Cancer Institute; Director, Duke Community Connections Core, Duke CTSA (Moderator)
Robert Winn, MD, Director and Lipman Chair in Oncology, VCU Massey Cancer Center
Nina Bickell, MD, MPH, Co-Lead, Cancer Prevention and Control, Tisch Cancer Institute
Randall A. Oyer, MD, Medical Director, Ann B. Barshinger Cancer InstitutePenn Medicine Lancaster General Health; ACORI Chair

Promoting Inclusion of Members of Racial and Ethnic Minority Groups in Cancer Drug Development
Lola A. Fashoyin-Aje, MD, MPH, Deputy Division Director, FDA Oncology Center of Excellence
Jennie R. Crews, MD, MMM, FACP, Medical Director, SCCA Network & Community Sites, Seattle Cancer Care Alliance
Erin Williams MBA, Associate Director, SCCC Clinical Research Operations, University of Texas Southwestern Medical CenterSimmons Comprehensive Cancer Center
Racquel Racadio, MPH, Senior Manager, Diversity and Representation in Clinical Research, Amgen

Day 2: Breakout Discussions

SU2C Special Session
Olajide Williams, MD, Founder and President, Hip Hop Public Health
Sung Poblete, PhD, RN, Chief Executive Officer, SU2C

Harnessing the Power of Community Partnerships to Improve Patient Accrual
Karen Winkfield, MD, PhD, Executive Director, Meharry-Vanderbilt Alliance

Building Research Capacity to Strengthen Cancer Trials in the Community
Lola A. Fashoyin-Aje, MD, MPH, Deputy Division Director, FDA Oncology Center of Excellence

Incorporating the Patient Perspective into Trial Design
Carla Strom, MLA, Assistant Director, Operations, Wake Forest Baptist Health Comprehensive Cancer Center

Key:

Complete
Failed
Available
Locked
Day One: Panel Discussions
Welcome and Patient Perspective
Open to view video.
Open to view video.
Advancing Health Equity through Community Cancer Research
Open to view video.
Open to view video. This panel was moderated by Sybil Green, JD, RPh, MHA (Diversity and Inclusion Officer, ASCO) and included Ysabel Duron (President/Executive Director, The Latino Cancer Initiative), Linda Burhansstipanov, MSPH, DrPH (President, Native American Cancer Initiatives), and Karen Winkfield, MD, PhD (Executive Director, Meharry-Vanderbilt Alliance). The panel focused on the evolving context around health equity in cancer research and the potential role for oncology programs and practices to play in advancing health equity through research.
Centering the Patient Perspective in Community Cancer Research
Open to view video.
Open to view video. This panel was moderated by Jeanne Regnante (Chief Health Equity and Diversity Officer, LUNGevity Foundation) and included Shonta Chambers, MSW (Executive Vice President of Health Equity and Community Engagement, Patient Advocate Foundation), Venus Ginés, MA, P/CHWI (CEO/ Founder, Día de la Mujer Latina), and Rodney Haring, PhD, MSW (Director, Center for Indigenous Research, Roswell Park Comprehensive Cancer Center). This discussion focused on the importance of bringing research to the community and of centering the patient and their experience throughout the research process.
Fostering Readiness for Community Cancer Research
Open to view video.
Open to view video. This panel was moderated by Nadine J. Barrett, PhD, MA, MS (Assistant Professor, Family Medicine and Community Health; Co-Director, Clinical and Translational Science Institute (CTSI); Director, Center for Equity in Research; Associate Director, Equity, Community and Stakeholder Strategy, Duke Cancer Institute) and included Nina Bickell, MD, MPH (Co-Lead, Cancer Prevention and Control, Tisch Cancer Institute), Randall A. Oyer, MD (Medical Director, Ann B. Barshinger Cancer Institute, Penn Medicine Lancaster General Health), and Robert Winn, MD (Director and Lipman Chair in Oncology, VCU Massey Cancer Center). Discussion centered on the potential of oncology programs and practices to conduct research and reach underserved communities and the common needs that they face in building institutional capacity to undertake such research.
Promoting Inclusion of Members of Racial and Ethnic Minority Groups in Cancer Drug Development
Open to view video.
Open to view video. The panel was moderated by Lola A. Fashoyin-Aje, MD, MPH (Associate Director, FDA Oncology Center of Excellence) and included Jennie R. Crews, MD, MMM, FACP (Medical Director, SCCA Network & Community Sites, Seattle Cancer Care Alliance), Erin Williams, MBA (Associate Director, Clinical Research Operations, University of Texas Southwestern Medical Center, Simmons Comprehensive Cancer Center), and Racquel Racadio, MPH (Senior Manager, Diversity and Representation in Clinical Research, Amgen). Conversation focused on inclusive drug development and a discussion of Dr. Fashoyin-Aje’s recent article, Promoting Inclusion of Members of Racial and Ethnic Minority Groups in Cancer Drug Development.
Day Two: Breakout Discussions
Day Two: Breakout Discussions
Open to view video.
Open to view video. Day two began with a presentation from Stand Up to Cancer highlighting a new research initiative to advance health equity in colorectal cancer screening, and a collaborative campaign with Hip Hop Public Health to spread awareness about the importance of colorectal cancer screening, specifically in Black and Hispanic/Latinx communities. Their presentation highlighted the importance of creating inclusive and culturally relevant materials to better reach diverse audiences. Attendees then participated in three breakout discussions focused on generating action items to address the issues articulated on Day 1. Each session included time for participants to brainstorm ideas, discuss and refine those ideas as a group, and finally prioritize ideas.